Hematoporphyrin Ether Ester

血卟啉醚酯

Report date: 2022/12/17 17:29:25

Base Information

Drug NameHematoporphyrin Ether Ester
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUndefined mechanism
TargetsNot applicable
Therapy Area/IndicationsPyelonephritisPulmonary Disease, Chronic ObstructiveTracheobronchomegaly +[8] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaPhase 3 Clinical
Originator CompaniesN/A
China Registration ClassN/A

Develop Information

Active CompaniesShenzhen Zhongxing Yangfan Bio-Engineering Co LtdWelman (Xiang Bei) Pharmaceuticals Ltd
Inactive CompaniesN/A
Active IndicationsPyelonephritisPulmonary Disease, Chronic ObstructiveTracheobronchomegaly +[8] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A